Business Description
Wellbiotec Co Ltd
ISIN : KR7010600005
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.87 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -7.78 | |||||
Beneish M-Score | -11.22 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19.1 | |||||
3-Year EBITDA Growth Rate | 48 | |||||
3-Year EPS without NRI Growth Rate | 2.6 | |||||
3-Year FCF Growth Rate | 30.6 | |||||
3-Year Book Growth Rate | -0.1 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 29.58 | |||||
14-Day RSI | 30.18 | |||||
12-1 Month Momentum % | -55.94 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.73 | |||||
Quick Ratio | 2.72 | |||||
Cash Ratio | 0.98 | |||||
Days Inventory | 7.53 | |||||
Days Sales Outstanding | 72.57 | |||||
Days Payable | 35.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.1 | |||||
Shareholder Yield % | 13.2 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 12.62 | |||||
Operating Margin % | -23.29 | |||||
Net Margin % | -121.12 | |||||
FCF Margin % | 3.43 | |||||
ROE % | -184.67 | |||||
ROA % | -125.67 | |||||
ROIC % | -39.63 | |||||
ROC (Joel Greenblatt) % | -125.12 | |||||
ROCE % | -32.34 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.8 | |||||
PB Ratio | 1.75 | |||||
Price-to-Tangible-Book | 1.76 | |||||
Price-to-Free-Cash-Flow | 24.03 | |||||
Price-to-Operating-Cash-Flow | 22.38 | |||||
EV-to-EBIT | -2.98 | |||||
EV-to-EBITDA | -3.25 | |||||
EV-to-Revenue | 0.66 | |||||
EV-to-FCF | 19.36 | |||||
Price-to-Median-PS-Value | 1.02 | |||||
Price-to-Net-Current-Asset-Value | 3.4 | |||||
Earnings Yield (Greenblatt) % | -33.56 | |||||
FCF Yield % | 4.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Wellbiotec Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 61,721.985 | ||
EPS (TTM) (â‚©) | -822.733 | ||
Beta | 1.4 | ||
Volatility % | 46.98 | ||
14-Day RSI | 30.18 | ||
14-Day ATR (â‚©) | 0.000151 | ||
20-Day SMA (â‚©) | 545 | ||
12-1 Month Momentum % | -55.94 | ||
52-Week Range (â‚©) | 519 - 1570 | ||
Shares Outstanding (Mil) | 90.92 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Wellbiotec Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Wellbiotec Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Wellbiotec Co Ltd Frequently Asked Questions
What is Wellbiotec Co Ltd(XKRX:010600)'s stock price today?
When is next earnings date of Wellbiotec Co Ltd(XKRX:010600)?
Does Wellbiotec Co Ltd(XKRX:010600) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |